SickScience uses biomimetic exosome technology to communicate with cells at the molecular level, delivering plant-based ...
A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...
As AI tools become more prevalent in the life sciences, biotechnology companies need to evaluate AI’s impact on their ability to protect the results of their research. Recent U.S. Patent and Trademark ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...
Good morning. I hope you’re having a better morning than this raccoon. Let’s get into the news today.
Jason P Rogers of James & Wells provides a guide to protecting pharmaceutical and biotech inventions in New Zealand, and previews the changes expected under proposed changes to the Patents Act In New ...
The Senate Judiciary Committee’s Intellectual Property Subcommittee held a critical hearing on the Patent Eligibility Restoration Act of 2025 (PERA), a bipartisan bill that seeks to restore clarity to ...
GlobalData on MSN
Crescent and Kelun-Biotech swap cancer asset rights in double deal
The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...
Over the past three decades biotechnology has evolved from a purely academic field of life sciences having little commercial value to an important branch of industry with a global turnover of more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results